Thanks for the info Michael!
Given first edition Trophon took 18 months i think they may be basing their timing of approval and sales of Coris on that schedule. Coris will probably be or have a number of novel elements so they will be cautious with the timing. (Trophon 2 was probably a lot less novel - to the FDA.)
I assume they will make an announcement once they submit to FDA (did they do that with Trophon?)
At that point i would guess investor enthusiasm will probably be reflected in the price trend. Until then I don't know what the share price will do.
As they keep adding new products to their lineup the sales process will get easier as customers will be aware of their products already. ( And when medical staff move to other hospitals they will also want to continue using it / recommend it).
Thanks for the info Michael!Given first edition Trophon took 18...
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.75 |
Change
-0.010(0.36%) |
Mkt cap ! $833.1M | |||
| Open | High | Low | Value | Volume |
| $2.73 | $2.76 | $2.71 | $1.479M | 541.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2044 | $2.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.76 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.76 |
Change
-0.010 ( 0.41 %) |
||||
| Open | High | Low | Volume | ||
| $2.72 | $2.76 | $2.71 | 172952 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| NAN (ASX) Chart |